Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AT13387 in Adults With Refractory Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ) Identifier:
First received: November 20, 2010
Last updated: September 28, 2016
Last verified: September 2016